Dr. Nayyar Syed
Medical Oncology
Texas, United States
Dr. Syed practices at 2 locations. See details below.About Dr. Syed
Dr. Syed is an Medical Oncology Specialist in Mt Pleasant and Dallas, Texas. He graduated from medical school in 1993. Dr. Syed accepts Medicare approved amount as full payment.
The medical group (Texas Onco) Dr. Syed works with accepts Medicare approved amount as full payment.
Full Name
Nayyar Syed
Specialty
Medical Oncology
Hematology/oncology, Internal Medicine
Hematology/oncology, Internal Medicine
School
Other
Graduated class of
1993
Locations
NPI
1154411635
PAC ID
2147483647
Clinician Enrollment ID
I20090429000500
Cities
2
Number of cities where Dr. Syed has officesOffices
2
Number of officesHospitals
2
Number of hospitalsOffice Locations
MT PLEASANT Office
Phone: (903) 434-4850
2101 Mulberry Ave
Mt Pleasant, TX - 75455-1105
DALLAS Office
Phone: (972) 566-7031
7777 Forest Ln
Suite D110
Dallas, TX - 75230-2567
Hospitals
TITUS REGIONAL MEDICAL CENTER
CMS Certification Number: 450080
CHRISTUS MOTHER FRANCES HOSPITAL- WINNSBORO
CMS Certification Number: 451381
Doctors and Clinicians Utilization Data
Specialty | HCPCS code | Code description | Service Count | Beneficiary count |
---|---|---|---|---|
Medical Oncology | 36415 | Insertion of needle into vein for collection of blood sample | 1957 | 537 |
Medical Oncology | 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 305 | 93 |
Medical Oncology | 96366 | Infusion into a vein for therapy, prevention, or diagnosis | 69 | 24 |
Medical Oncology | 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 227 | 47 |
Medical Oncology | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 696 | 80 |
Medical Oncology | 96413 | Infusion of chemotherapy into a vein up to 1 hour | 626 | 78 |
Medical Oncology | G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation | 529 | 95 |
Medical Oncology | J0897 | Injection, denosumab, 1 mg | 3540 | 11 |